Kusaka Yusuke, Ueno Takeshi, Minami Toshiaki
Department of Anesthesiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan.
J Anesth. 2025 Feb;39(1):101-110. doi: 10.1007/s00540-024-03439-w. Epub 2024 Dec 16.
Currently, laparoscopic surgery is a standard technique in the field of abdominal surgery. However, the most adequate fluid regimen during laparoscopic surgery remains unclear. The aim of this trial is to compare a restricted fluid therapy with a liberal fluid therapy for laparoscopic abdominal surgery. Our hypothesis was that restrictive fluid therapy would reduce postoperative complications better than liberal fluid therapy.
In this randomized controlled trial, patients scheduled for laparoscopic gastric surgery were randomized to either the liberal group (receiving 7-10 ml/kg/h of crystalloid) or the restrictive group (receiving 1-2 ml/kg/h of crystalloid) for each stratum of surgical procedure from April 2017 to March 2019. For both groups, blood loss was replaced by an equal volume of hydroxyethyl starch. The primary endpoint was postoperative complications up to 30 days after surgery, according to the Clavien-Dindo classification.
We enrolled 148 patients, and 140 of these were randomized to either the liberal or the restrictive group after exclusion. As a result, 69 cases were included in the liberal group for analysis, and 67 patients composed the restrictive group. Median fluid administration for the liberal and restrictive groups was 2950 ml and 800 ml, respectively. As well, overall complications in the liberal and restrictive groups were 27.5% and 19.4%, respectively (risk ratio 0.71, 95% confidence interval 0.38-1.31, p value = 0.264).
Restricted fluid therapy and liberal fluid therapy did not show any statistical differences in postoperative complications after laparoscopic gastric surgery.
目前,腹腔镜手术是腹部外科领域的一项标准技术。然而,腹腔镜手术期间最适宜的液体治疗方案仍不明确。本试验的目的是比较腹腔镜腹部手术中限制性液体治疗与开放性液体治疗的效果。我们的假设是,限制性液体治疗比开放性液体治疗能更好地减少术后并发症。
在这项随机对照试验中,2017年4月至2019年3月期间,计划接受腹腔镜胃手术的患者根据手术步骤的不同分层,随机分为开放性治疗组(接受7-10毫升/千克/小时的晶体液)或限制性治疗组(接受1-2毫升/千克/小时的晶体液)。两组均用等量的羟乙基淀粉补充失血。主要终点是根据Clavien-Dindo分类法得出的术后30天内的并发症情况。
我们共纳入148例患者,排除后140例被随机分为开放性治疗组或限制性治疗组。结果,开放性治疗组纳入69例进行分析,限制性治疗组有67例患者。开放性治疗组和限制性治疗组的液体输注中位数分别为2950毫升和800毫升。此外,开放性治疗组和限制性治疗组的总体并发症发生率分别为27.5%和19.4%(风险比0.71,95%置信区间0.38-1.31,p值=0.264)。
腹腔镜胃手术后,限制性液体治疗和开放性液体治疗在术后并发症方面未显示出任何统计学差异。